Mir Imran: Difference between revisions

Mir Imran
Mir Imran
	File:Mir Imran.jpg Mir Imran
Born	May 14, 1956; Hyderabad, India
Occupation(s)	Founder and Managing Director, InCube Ventures (ICV)
Website	Profile of Mir at InCube Ventures

Browse history interactively

← Previous edit Next edit →

Content deleted Content added

VisualWikitext

Inline

Revision as of 20:49, 21 November 2007

Mir A. Imran (born 1956, Hyderabad, India), is an Indian entrepreneur and Venture Capitalist. Mir has formed 19 companies since the early 80’s and holds over 140 patents.

Born and raised in India, the son of a Doctor, Mir moved to New Jersey in 1973 to attend Rutgers University where he studied both electrical and biomedical engineering. He received his B.S. in Electrical Engineering and his M.S. in Bio Medical Engineering and attended three years of Medical School before deciding to leave and work on the first Implantable Cardioverter-Defibrillator with Intec Systems, which was acquired by Eli Lilly, spun out to form Guidant, and acquired by Boston Scientific in 2006 for $27.5B

Mir is recognized for his history as a scientist, inventor, entrepreneur and investor of medical technology companies. He is the founder and Chairman of InCube Laboratories, Inc. (http://incubelabs.com), a research laboratory and business incubator for medical and technology companies. Through InCube Labs, and prior to its establishment, he has founded numerous medical and high technology companies. Mr. Imran currently serves as a Director for NFocus, Inc., Zonare, Inc., Intrapace, Inc., Entrack, Inc., SafeView, Inc., Bodymedia, Inc., EGeen Inc. Acumen Medical Inc., Python Medical, Inc., Corrhythm, Inc. and Neurolink, Inc.

Business

Mir’s joined Intec Systems in 1980 and developed IP key to the development of the automatic implantable defibrillator, a device that has saved hundreds of thousands of lives, and has become a standard of care in cardiology. One of his high profile medical inventions is his EEG monitoring sensor array that John Glenn was featured as wearing in the Time Magazine story of his latest space mission. This became the core product for Physiometrix and has become a standard diagnostic tool used in neurophysiology. In 1992, Mr. Imran invented a cooled RF ablation catheter for the treatment of ventricular arrhythmias. This invention became the initial product of Cardiac Pathways, and is now widely used by cardiac electro-physiologists. In 1995, he developed a low-pressure balloon and aspirator system for use in catheter based interventions. Mr. Imran was the first to articulate the concept of distal protection during high-risk interventions. Mr. Imran’s device became the primary innovation for Percusurge, which was acquired by Medtronic in December 2000. In the medical field Mir’s interest is to develop medical devices that blur the distinction between organic and synthetic and advance patient treatment options.

Mir’s current research interests include tissue engineering, gastroenterology, nephrology, neurology, orthopedics, congestive heart failure and artificial organs.

DFJ

Mr. Imran is an active angel investor and a limited partner in several venture funds. In addition, he serves as an Advisor to Alley Ventures and is a Venture Partner and an Advisor of DFJ ePlanet Ventures, a $650 million global venture capital fund, based in Silicon Valley.

Companies formed by Mir

Over his 25 year career, Mir has founded 19 companies, including:

Data Trak, Inc. – Real Estate Lockbox Encryption Technology developer. Acquired by Supra Products in 1989
Cardiac Pathways, Inc. –Ventricular tachycardia and atrial fibrillation mapping and ablation devices. IPO 1996, Acquired by Boston Scientific in 2001, Mir - Founder, Director (1991-1996)
Vidamed, Inc. – Licensed Patents and technology relating to Trans Urethral Needle Ablation for the treatment of Benign Prostate Hyperplasia, BPH. IPO 1995, Acquired by Medtronic in 1996.
Intella Interventional, Inc. - Novel devices for coronary angioplasty. Merged with Goodman Inc. in March 2000, Mir - Founder, Director (1993-99)
Reflow, Inc. - Devices for Chronic total occlusions. Merged with FHT, Inc. in 1999, Mir - Founder, Chairman of the Board
Surface Genesis, Inc. - Bio materials research (Shut Down) Mir - Founder, Chairman of the Board.
Percusurge, Inc. – Pioneered the area of emboli protection during interventional procedures. Acquired by Medtronic in 2000, Mir - Founder, Director (1995-2000)
Advanced Cytometrix - Devices for soft tissue biopsy. Merged with Oncotech Inc. in 1997 Mir - Founder, President & CEO, Director
Physiometrix, Inc. EEG devices to monitor brain activity and determine depth of anesthesia. , IPO 1996, Acquired by Hospira Mir- Founder, Director (1990-1996)
Safeview, Inc. – Developer of Millimeter wave length security imaging equipment. Acquired by L3 Communications, Mir - Co-Founder, Director, Investor
Intrapace, Inc. – Developing a Gastric Stimulator for the treatment of Obesity.
Zonare, Inc. – Pre-IPO company that manufactures Portable Ultrasound Systems, Mir - Co-Founder
Spinal Modulation – Early Stage Company with a treatment for patients with chronic pain.
Entrack Medical, Inc. – Startup in Stealth Mode
Python Medical, Inc. – Startup in Stealth Mode
Corrhythm, Inc. – Startup in Stealth Mode
Neurolink, Inc. – Startup in Stealth Mode

InCube Labs

Mir founded InCube Labs in 1995 after forming 8 venture backed medical device companies. Mir’s concept was that InCube would function as an applied research institute, validating some early stage experiments to allow for a more efficient company formation process. Since the formation of InCube Labs, Mir has formed 11 more companies, 5 of which are currently incubating within the facility .http://www.incubelabs.com

InCube Ventures

Founded in 2006, InCube Ventures is currently raising a venture capital fund that will invest both in companies that are created in InCube Labs as well as by individuals outside of InCube. http://www.incubevc.com

Awards and Publications

2005 Rutgers University Distinguished Engineer Award

Featured in EE Times - Nov 7th 2005 eeTimes Website

Featured in Stanford Medicine - Fall 2006 Stanford Medicine Magazine Website

Featured in Rutgers 1766 Alumni Magazine Rutgers 1766 Magazine Website

Featured in Innovative Doctoring-Grossman, Jeffrey Innovative Doctoring Book Website

Speaking Engagements

Mir Imran - Medtronic Distinguished Lecturer at Johns Hopkins BioMedical Engineering Day – May 2007 Johns Hopkins BioMedical Engineering Day Brochure – May 2nd 2007

Mir Imran – Keynote Speaker – Engineering in Medicine and Biology - UT Dallas - Nov 2007 UT Dallas Engineering in Medicine and Biology Website

Quotes

"I focus all my energies on problem solving and the clinical problem, the disease process, the existing therapies and how well they work. Once you understand where the problems are, inventing a new therapy can be a simple consequence of that understanding." * EE Times Nov 7th 2005

External links

@@ Line 80: / Line 80: @@
 ==Quotes==
-*"I focus all my energies on problem solving and the clinical problem, the disease process, the
+*"I focus all my energies on problem solving and the clinical problem, the disease process, the existing therapies and how well they work. Once you understand where the problems are, inventing a new therapy can be a simple consequence of that understanding." * [http://www.eetimes.com/showArticle.jhtml;jsessionid=OE1Y5CD3QTGACQSNDLPSKHSCJUNN2JVN?articleID=173403095/ EE Times Nov 7th 2005]
-existing therapies and how well they work. Once you understand where the problems are,
-inventing a new therapy can be a simple consequence of that understanding." * [http://www.eetimes.com/showArticle.jhtml;jsessionid=OE1Y5CD3QTGACQSNDLPSKHSCJUNN2JVN?articleID=173403095/ EE Times Nov 7th 2005]